DOVER, Del. (AP) — Soft demand for a key industrial pigment and solar energy products, coupled with increased spending on growth initiatives, led to a sharp drop in the DuPont Co.'s fourth-quarter income.
But the results reported Tuesday still beat the consensus estimate of Wall Street analysts of 7 cents per share on revenue of $7.2 billion, according to FactSet. And the company forecast higher operating earnings for 2013.
DuPont's shares rose 83 cents, or 1.8 percent, to close at $47.82 Tuesday. They are still down 11 percent from their high for the past year of $53.98 set last May.
DuPont chairwoman and CEO Ellen Kullman said the company is stronger than it was a year ago, having recorded nearly 2,300 new product introductions in 2012, an increase of 30 percent.
"However, weakness in markets served by performance chemicals and electronics and communications provided significant challenges in 2012," she said. "We've adjusted our plans to meet the changing market environment and grow our businesses in a slow-growth world economy."
The Wilmington, Del.-based chemical and biosciences company reported Tuesday that its net income fell to $111 million, or 12 cents per share, for the last three months of 2012. That is down 70 percent from $373 million, or 40 cents per share, for the fourth quarter of 2011.
Revenue for the quarter was flat at $7.3 billion, with currency effects and portfolio changes offsetting a 3 percent increase in global volumes. Sales in Latin America grew 10 percent, with an 8 percent volume gain and a 7 percent increase in local prices. A 6 percent increase in volume in the Asia-Pacific region, was offset by negative currency and pricing effects.
For the full year, DuPont earned almost $2.8 billion, or $2.95 per share, on revenue of $34.8 billion. That's down from last year's net income of almost $3.5 billion, or $3.68 per share, on revenue of $33.7 billion. Sales volumes fell 2 percent.
DuPont said it expects operating earnings excluding significant items will range from $3.85 to $4.05 per share in 2013, up from $3.77 per share last year.
One-time items affecting fourth-quarter results included $135 million to resolve legal claims stemming from the use of DuPont's Imprelis weedkiller, bringing the total amount spent on Imprelis claims to $750 million.
DuPont chief financial officer Nick Fanandakis said the company was working to validate and resolve claims regarding damage to trees, particularly evergreens such as Norway spruce and white pine, linked to the weed killer.
Continue reading this story on the...